BIOBio-Rad Laboratories, Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Choppy, but holding above its 200-day average. Price is +19% vs its 200-day average.
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 18% since the previous count, down from 7.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BIO is trading
Bio-Rad Laboratories, Inc. is +18% over the past year while the S&P 500 is +16%: 2.5 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +19%
vs 200-day average · a clear uptrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 5.2%
Below its 52-week high
Details›
- Last close2026-10-23
- $370.14
- 1 monthS&P 500 −0.94%
- −4.5%
- 1 yearS&P 500 +16%
- +18%
- 5 yearsS&P 500 +86%
- −48%
- vs 50-day average$372.45
- −0.62%
- 52-week high
- $390.31
- 52-week low
- $241.71
- Annualised volatility
- 41%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $136K
| Year | Return |
|---|---|
| 2026 (year to date) | +22% |
| 2025 | −7.8% |
| 2024 | +1.7% |
| 2023 | −23% |
| 2022 | −44% |
| 2021 | +30% |
| 2020 | +58% |
| 2019 | +59% |
| 2018 | −2.7% |
| 2017 | +31% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.3% |
| Feb | 10 | 7 of 10 | −0.89% |
| Mar | 10 | 5 of 10 | −0.65% |
| Apr | 10 | 6 of 10 | +0.90% |
| May | 10 | 6 of 10 | +1.7% |
| Jun | 10 | 6 of 10 | −0.15% |
| Jul | 11 | 11 of 11 | +9.2% |
| Aug | 11 | 6 of 11 | +3.5% |
| Sep | 11 | 3 of 11 | −2.9% |
| Oct | 11 | 4 of 11 | −1.6% |
| Nov | 10 | 7 of 10 | +5.7% |
| Dec | 10 | 6 of 10 | −1.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.